Cargando…
Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
Myeloid malignancies including myelodysplastic syndromes, myeloproliferative neoplasms and acute myeloid leukemia are heterogeneous disorders originating from mutated hematopoietic stem and progenitor cells (HSPCs). Genetically, they are very heterogeneous and characterized by uncontrolled prolifera...
Autores principales: | Andina, Nicola, Bonadies, Nicolas, Allam, Ramanjaneyulu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829542/ https://www.ncbi.nlm.nih.gov/pubmed/35155452 http://dx.doi.org/10.3389/fcell.2021.825611 |
Ejemplares similares
-
Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
por: Chaib, Mehdi, et al.
Publicado: (2020) -
Neuronal Mitophagy: Friend or Foe?
por: Doxaki, Christina, et al.
Publicado: (2021) -
Post-stroke Neurogenesis: Friend or Foe?
por: Cuartero, María Isabel, et al.
Publicado: (2021) -
Autophagy and Exosomes Relationship in Cancer: Friends or Foes?
por: Colletti, Marta, et al.
Publicado: (2021) -
The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
por: Xu, Jing-Li, et al.
Publicado: (2020)